Deferoxamina Mesilato shortage status
1 active shortage notice across 1 country.
Last updated 1 Aug 2026 · sourced from official medicines regulators
- Generic name (INN)
- Deferoxamina Mesilato
- Brand names
- Desferal
- Class
- Auto-created by Agenzia Italiana del Farmaco — Carenze scraper
Where Deferoxamina Mesilato is in shortage
Why Deferoxamina Mesilato is in shortage
- manufacturing problems — e.g. “Problemi produttivi: distribuzione contingentata” (Italy)
Frequently asked questions
Is Deferoxamina Mesilato currently in shortage?
Yes. As of the latest regulator updates, Deferoxamina Mesilato has 1 active shortage notice across 1 country (Italy). Status is refreshed daily from official regulatory sources.
Why is Deferoxamina Mesilato in shortage?
Regulators attribute the current Deferoxamina Mesilato shortages to manufacturing problems. The exact cause varies by country and product — each notice on this page links to the official source.
Where does this Deferoxamina Mesilato shortage data come from?
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Get alerted when Deferoxamina Mesilato status changes
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.